Patent · US Active

Stabilized cabazitaxel formulations

US10188626B2 · kind B2 · utility

0Cited by

7References

30Claims

0Family size

Assignee

Cipla Limited · IN

Inventors

Geena Malhotra · Jamkhed, IN
Sarabjit Singh · Navi Mumbai, IN
Ravichandra Bhadravathi Vedamurthy · Jamkhed, IN
Anirban Mallik Thakur · Jamkhed, IN
Dhiraj Abhyankar · Mumbai, IN

Key dates

Filing date	Nov 3, 2016
Grant date	Jan 29, 2019
Priority date	—
Expiry date	Nov 3, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/42
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are improved formulations for the cabazitaxel. The formulations exhibit increased storage stability relative to other formulations, and are simpler for health care providers to prepare and administer to patients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.